https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3AGLP-1_receptor_agonist%2F19%2FenTranslations:GLP-1 receptor agonist/19/en - Revision history2026-11-02T08:46:38ZRevision history for this page on the wikiMediaWiki 1.43.0https://wiki.tiffa.net/w/index.php?title=Translations:GLP-1_receptor_agonist/19/en&diff=110969&oldid=prevFuzzyBot: Importing a new version from external source2024-02-05T12:59:57Z<p>Importing a new version from external source</p>
<p><b>New page</b></p><div>==Cost==<br />
GLP-1 agonists are more expensive than other treatments for type 2 diabetes. A study compared the cost effectiveness of GLP-1 agonists to [[long-acting insulin]] in Taiwanese type 2 diabetes patients. In patients with CVD, GLP-1 agonists were estimated to save money due to fewer cardiovascular incidents. In patients without CVD, the cost per QALY was $9,093. In the United States, cost is the highest barrier to GLP-1 agonist usage and was reported as the reason for discontinuation in 48.6 percent of US patients who stopped using the drugs. According to another study, GLP-1 agonists are not cost effective for pediatric obesity in the United States.</div>FuzzyBot